Saturn V Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-348,364
| Closed | -$16.4M | – | 23 |
|
|
2024
Q4 | $16.4M | Buy |
348,364
+17,081
| +5% | +$803K | 6.42% | 6 |
|
|
2024
Q3 | $17.5M | Buy |
331,283
+59,247
| +22% | +$3.13M | 6.25% | 7 |
|
|
2024
Q2 | $14.7M | Buy |
272,036
+8,335
| +3% | +$452K | 5.57% | 6 |
|
|
2024
Q1 | $18.5M | Sell |
263,701
-184,443
| -41% | -$12.9M | 7.41% | 3 |
|
|
2023
Q4 | $37.4M | Sell |
448,144
-47,024
| -9% | -$3.93M | 14.32% | 1 |
|
|
2023
Q3 | $14.6M | Buy |
495,168
+88,943
| +22% | +$2.62M | 6.11% | 7 |
|
|
2023
Q2 | $13.3M | Buy |
406,225
+123,339
| +44% | +$4.02M | 7.35% | 4 |
|
|
2023
Q1 | $9.95M | Buy |
282,886
+85,904
| +44% | +$3.02M | 7.44% | 6 |
|
|
2022
Q4 | $7.97M | Buy |
+196,982
| New | +$7.97M | 6.62% | 5 |
|